Clinical Trials Sponsored by Kao Corporation

Total 9031 results

Cangene Corporation

Approved for marketing

Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection

Varicella
Exsar Corporation

Suspended

Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease

Type I Gaucher Disease

United States
Quidel Corporation

Completed

Sofia RSV FIA Field Study

Respiratory Syncytial Virus

United States
Theravant Corporation

Completed

Effects of Acleara Needle Insert on Acne

Acne Vulgaris

United States
Adimmune Corporation

Completed

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2012-2013, in Non-Elderly Adult and Elderly Subjects

Influenza

Taiwan
Cordis Corporation

Terminated

An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II) (NEVO II)

Atherosclerotic Coronary Artery Disease

Spain, Switzerland, Netherlands
Quidel Corporation

Terminated

Sofia Strep A FIA Field Study

Strep Throat | Group A Streptococcus

United States
Haemonetics Corporation

Completed

Thromboelastography (TEG) Reference Range Study

Coagulation

United States
Yuhan Corporation

Completed

Comparative Pharmacokinetics of YH14659 in Healthy Male Subjects

Acute Coronary Syndrome

Korea, Republic of
Yuhan Corporation

Completed

A Phase 1 Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers

Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR

Korea, Republic of
Adimmune Corporation

Completed

Immunogenicity and Safety of AdimFlu-S, Formulation 2010-2011, in Infants Aged Between 6-12months Old

Influenza

Taiwan
Mannkind Corporation

Completed

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States
Mannkind Corporation

Completed

Pharmacokinetic Study in Healthy Volunteers

Healthy Volunteers

United States
Nymox Corporation

Completed

Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)

Benign Prostatic Hyperplasia (BPH) | Enlarged Prostate

United States
Mannkind Corporation

Completed

A Study to Determine if Technosphere® Inhalation Powder (FDKP) Causes ECG Changes (QTc) Following the Medication's Inhaled Administration.

Healthy Subjects

United States
Mannkind Corporation

Terminated

Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Asthma

Brazil, United States, Canada, Poland, Russian Federation, Argentina, Czech Republic, Mexico, Spain, Ukraine, United Kingdom
Mannkind Corporation

Completed

Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus
Incyte Corporation

Terminated

Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer

Breast Cancer

United States
Revalesio Corporation

Completed

Safety Study of Nebulized RNS60 to Treat Asthma.

Asthma

United States
Yuhan Corporation

Completed

Comparative Pharmacokinetics of YH14659 (YH14659)

Acute Coronary Syndrome

Korea, Republic of
Adimmune Corporation

Completed

A Pharmacovigilance Study for AdimFlu-S (A/H1N1) Influenza Vaccine in Pregnant Women

Adverse Drug Reactions
Mannkind Corporation

Completed

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Melanoma (Skin)

United States
Quidel Corporation

Completed

"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"

Influenza

United States
Mannkind Corporation

Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Melanoma | Small Cell Lung Carcinoma | Gastric Cancer | Mesothelioma | Breast Carcinoma | Cervical Carcinoma | Endometrial Carcinoma | Thyroid Cancer | Liver Cancer | Biliary Tract Cancer | Esophageal Carcinoma | Pancreatic Carcinoma | Gallbladder Cancer | Anal Carcinoma | Testicular Cancer | Neuroendocrine Cancer | Colore... and other conditions

United States
Cordis Corporation

Completed

The Intra-Drug Eluting Stent (DES) Restenosis Study (CRISTAL)

Coronary Artery Disease

France
NovoStent Corporation

Unknown

SAMBA EU Femoropopliteal Trial

Peripheral Vascular Disease

Germany
Omeros Corporation

Completed

Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones

Urinary Calculi | Urinary Stones | Urinary Tract Stones

United States
Cordis Corporation

Completed

The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent (SUPER SL)

Arterial Occlusive Diseases

Germany
Cordis Corporation

Completed

A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions (SCORPIUS)

Coronary Artery Disease

Germany
Repligen Corporation

Completed

Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas

Pancreatitis
Cordis Corporation

Completed

Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions (3D)

Coronary Artery Disease

Brazil
Mannkind Corporation

Completed

To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.

Diabetes Mellitus, Type 2

Germany
Cordis Corporation

Completed

Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)

Coronary Artery Disease

United States
Cordis Corporation

Completed

The Study to Assess AMI Treated With Balloon Angioplasty. (TYPHOON)

Coronary Artery Disease

France, Germany
EpiCept Corporation

Completed

A Safety Study of EPC2407, A Anti-Cancer Drug With Vascular Disrupting Activity: In Patients With Advanced Cancer

Advanced Cancer

United States
Neurogen Corporation

Terminated

Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease

Early Parkinson Disease

United States
Erchonia Corporation

Completed

Low Level Laser Light Therapy as an Aid to Liposuction

Pain
Cordis Corporation

Completed

The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions. (E-SIRIUS)

Coronary Artery Disease

Germany
Guidant Corporation

Completed

Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA Class

Atrial Fibrillation | Heart Block | Bradycardia | Sick Sinus Syndrome

Germany
Genaera Corporation

Completed

An Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers

Obesity | Diabetes Mellitus

United States
Guidant Corporation

Completed

Canadian Registry of ICD Implant Testing Procedures

Ventricular Fibrillation
Cordis Corporation

Completed

Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF)

Pulmonary Embolism
Biopure Corporation

Completed

Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization

Myocardial Infarction | Angina Pectoris | Unstable Angina

Belgium, Germany, Netherlands
AmpliMed Corporation

Completed

Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy

Neoplasm Metastasis

United States
Cordis Corporation

Completed

Distal Protection Combined With PTCA in AMI Patients (DIPLOMAT)

Coronary Artery Disease

France
Guidant Corporation

Completed

Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With the CRT Pacemaker Renewal TR2

Congestive Heart Failure

France
Cordis Corporation

Completed

FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

Coronary Artery Disease

Netherlands
Guidant Corporation

Terminated

REBEAT Resynchronisation and Beta-Blocker European Trial

Heart Failure

Switzerland, Italy
Corixa Corporation

Unknown

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Celgene Corporation

Completed

Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer

Breast Neoplasms | Metastases, Neoplasm

United States

3

Subscribe